This Is Cancer Research at Its Best
Kosan Biosciences is a pharmaceutical company that deals with cancer therapeutics medications. The company is currently working on advancing two new classes of anticancer agents through clinical development. Founded in 1995, Kosan is headquartered in Hayward, California, and currently has approximately 90 employees. Kosan was funded in part as a venture capital startup with funds from Sofinnova Ventures of California.
Following the company’s IPO, we were hired to improve the financial messaging and aesthetics. The goal was to help the audience more clearly understand the technology relevance and how it fits into the developing landscape devoted to new treatment options for patients.
Acquired by Bristol-Myers Squibb for $190 million.